Letter: Lichenoid eruption induced by etanercept.

Abstract

Lichenoid drug eruption is an uncommon, but previously reported, side effect of anti-tumor necrosis factor therapy. The majority of these adverse events relate to infliximab. We report a patient who developed a lichenoid eruption on the back of her hands during etanercept therapy. She improved with topical treatment and discontinuation of the drug was not necessary. The physiopathological link between anti-TNF treatment and lichenoid eruptions remains unclear. It is important to realize that a lichenoid reaction pattern may occur during anti-TNF agent treatment.

• Authors: Nuria Barrientos, Sagrario García-Sánchez, José D Domínguez
• Journal: Dermatology online journal (Dermatol Online J) Vol. 18 Issue 7 Pg. 15 (Jul 15 2012) ISSN: 1087-2108 [Electronic] United States
• PMID: 22863637 (Publication Type: Case Reports, Letter)

Chemical References

• Anti-Inflammatory Agents
• Antirheumatic Agents
• Immunoglobulin G
• Pregnadienediols
• Receptors, Tumor Necrosis Factor
• Mometasone Furoate
• Etanercept

Topics

• Administration, Topical
• Anti-Inflammatory Agents (therapeutic use)
• Antirheumatic Agents (adverse effects)
• Arthritis, Rheumatoid (drug therapy)
• Drug Eruptions (diagnosis, drug therapy)
• Etanercept
• Female
• Humans
• Immunoglobulin G (adverse effects)
• Lichenoid Eruptions (chemically induced, drug therapy)
• Middle Aged
• Mometasone Furoate
• Pregnadienediols (therapeutic use)
• Receptors, Tumor Necrosis Factor
• Severity of Illness Index
• Treatment Outcome